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Abstract
Maternal vitamin D deficiency in pregnancy is a widespread public health con-
cern. Race and ethnicity as biological and cultural factors, respectively, can affect 
vitamin D status through differences in skin color, sunlight exposure, and dietary 
intake. Low maternal vitamin D status in pregnancy may affect both mother and 
fetus adversely. Vitamin D deficiency and insufficiency are linked to a wide variety 
of adverse pregnancy outcomes such as gestational diabetes, preeclampsia, and 
preterm delivery. Furthermore, maternal vitamin D deficiency has been linked to 
several adverse health outcomes in infants and children. The examples include, but 
not limited to, impaired growth, skeletal problems, and autoimmune diseases such 
as type 1 diabetes and asthma. This chapter reviews the vitamin D status during 
pregnancy across different ethnic groups, looking into the adverse pregnancy and 
child outcomes, followed by a discussion on the association between maternal and 
child vitamin D status and successful interventions. Strong evidence exists about 
the association between vitamin D and some health outcomes during pregnancy, 
while more studies are needed to confirm the other claim. The existing body of 
evidence justifies the need for well-designed policies and systematic interventions 
to ensure optimal vitamin D status of pregnant women and their offsprings across 
different ethnic and racial groups.
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1. Introduction
The calciotropic role of vitamin D is well known from the early twentieth cen-
tury. The recent advances in research opened a new perspective about vitamin D as 
prohormone with receptors in most tissues of the human body [1, 2]. This indicates 
additional non-calciotropic effects of vitamin D, such as its role in autoimmunity, 
chronic disease, infectious diseases, mental health issues, etc. [2]. However, the 
current dietary recommendations are based on only calciotropic effects of vitamin 
D although recent studies suggest that higher intakes are required to achieve the 
optimal vitamin in D status for both calciotropic and non-calciotropic benefits of 
vitamin D [2].
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Pregnancy is a unique stage of life for women when the normal physiology of 
mother is changing in order to provide the nutritional needs for the growing fetus 
[3]. Those changes influence the vitamin D hemostasis and availability for the 
mother and the fetus. In this chapter, we provide an overview of the evidence about 
vitamin D metabolism during pregnancy, the association between maternal vitamin 
D status and pregnancy, fetal and postnatal outcomes. Further, we provide insight 
into the current recommendation for vitamin D intake to achieve optimal vitamin D 
status and the associated factors, particularly race and ethnicity. Finally, we review 
the existing policies and practices to assure optimal vitamin status in pregnant 
women and their offsprings.
2. Vitamin D metabolism during pregnancy
Vitamin D homeostasis is altered during pregnancy in order to provide a suc-
cessful delivery and optimal environment for the growth of the fetus. This section 
focuses on adaptive changes of vitamin D during pregnancy as a background for 
developing pregnancy and fetal related disorders.
Major vitamin D adaptations in pregnancy include: (1) maternal increase of 
calcitriol; (2) availability of maternal 25(OH)D for optimal neonatal 25(OH)D;  
(3) increased concentration of maternal vitamin D-binding protein (VDBP) 
and placental vitamin D receptor (VDR); and (4) increased activity of renal and 
placental 25(OH)D-1-α-hydroxylase (CYP27B1) [4, 5]. The first change is started 
in the first trimester, increasing the level of calcitriol in systemic circulation and 
placenta to 100–200% by the end of the third trimester [6]. It is originated mostly 
from the kidneys for the purpose of increased intestinal calcium absorption during 
pregnancy [7]. In fact, the activity of 1α hydroxylase increases while catabolism 
of calcitriol decreases leading to more intestinal calcium absorption and immune 
adaptation [8]. The additional contributors of increased maternal and placental cal-
citriol are prolactin, calcitonin, PTH-related peptide (PTH-rP), estradiol, placental 
lactogen [9], IGF-1 [10], and FGF23 [11]. Any dysregulation causing activation 
decrease and catabolism increase of 25(OH)D may lead to preeclamptic mothers, 
which will be discussed in this chapter [12].
The second adaptation is likely that the levels of 25(OH)D in cord blood are 
reduced on average 25% in comparison with maternal 25(OH)D [13]. Maternal 
25(OH)D concentration remains constant during pregnancy, meaning that the 
increased level of calcitriol is not related to its precursor synthesis. Maternal 
25(OH)D crosses the placenta barrier as the main source of vitamin D in the fetus 
[14]. Therefore, vitamin D insufficiency in pregnant mothers could affect the fetus. 
Other factors, including lifestyle, place of living, skin pigmentation, sunshine 
exposure, and obesity, contribute significantly to maternal vitamin D status during 
pregnancy [4]. Consequently, a low level of maternal vitamin D leads to impaired 
fetal 25(OH)D at birth.
The third adaptation is a 40–50% increase in the concentration of VDBP in 
both systemic circulation and placenta level compared to the non-pregnant woman 
reaching to a maximum level at the beginning of the third trimester, before start-
ing to decrease by the end of gestation. This leads to a consistent decrease of free 
25(OH)D from 15 to 36 weeks, since there is an inverse relationship between free 
25(OH)D and VDBP concentration [15]. The mechanism has not fully understood, 
although studies suggested the high turnover rate of trophoblasts that are in contact 
with maternal blood directly leads to the increased expression of VDBP on the 
cell-surface of human placental trophoblasts during normal human pregnancy [16]. 
Studies conducted by Ma et al. and Liong et al. indicated that VDBP impairment, 
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either increase or decrease of its concentration, can contribute to the pathogenesis 
of preeclampsia (PET) and preterm birth [16, 17].
The placenta is an important organ playing a pivotal role in the optimal embry-
onic improvement and healthy pregnancy. Placenta regulates vitamin D metabolism 
by its own mechanism [18]. In fact, 1-α-hydroxylase, 24-hydroxylase, VDBP, and 
VDR have all been detected in trophoblast cultures and in placenta tissue, result-
ing in local synthesis of 1,25(OH)2D in the maternal-fetal interface as extrarenal 
calcitriol. Moreover, in the placenta, VDR gene expression is higher within the 
first and second trimester compared to term placentas [19] and positively asso-
ciated with transferring of calcium from mother-to-fetal. This indicates that 
VDR-dependent mechanisms in the placenta can affect fetal skeletal growth [20]. 
Vitamin D2 is metabolized in the placenta as well [21]. Thus, the placenta has its 
own mechanism in the regulation of vitamin D metabolism.
Increased 1, 25(OH)D is attributed to the higher activity of CYP27B1 in 
maternal, kidney, placental trophoblasts, and decidua during pregnancy [22]. The 
mechanism by which CYP27B1 activity increases in pregnancy remains unclear. 
However, it has been suggested that PTH analog PTH-related peptide (PTH-rP), 
synthesized by fetal parathyroid and placenta, could be a potential regulatory factor 
for CYP27B1 and augments during pregnancy [23].
Vitamin D metabolism manifests significant changes in pregnant women 
compared to the non-pregnant state. In an optimal ongoing pregnancy, there are 
three striking alternation within a gestation; two-fold increase of calcitriol in the 
first trimester, versus about 25% reduction in the levels of 25(OH)D in cord blood 
as it crosses the placenta barrier and increase the expression of vitamin D receptor 
and regulatory metabolic enzymes in the placenta. Also, maternal increase of serum 
calcitriol and VDBP without changes in 25(OH)D and calcium concentration of 
mother indicates that neonatal vitamin D stores are dependent on maternal vitamin 
D status.
3.  Current vitamin D intake recommendation guideline during 
pregnancy
The role of vitamin D intake in pregnancy and its consequences for fetal growth 
is the focus of current attention. The previous Dietary Reference Intake (DRI) 
review of vitamin D and Institute of Medicine (IOM) workshop on DRI research 
needs requested for research to evaluate the intake requirements for vitamin D as 
related to optimal circulating 25(OH)D concentrations across different life cycles 
and among different ethnic groups of Canadian and US populations [1]. Table 1 
summarizes different recommendations from various agencies which represents in 
population and individual level.
Health Canada [28] and IOM [1] have recommended dietary allowance of 
600 IU/day and tolerable upper intake level of 4000 IU/day for pregnant women 
in the US and Canada would meet the daily need in 97.5% of the population. There 
is no consensus on the cut-off point for vitamin D insufficiency. To prevent rickets 
and osteomalacia, IOM recommended >50 nmol/L concentration of 25(OH)D. 
While, the Endocrine Society and Osteoporosis Canada suggested a target serum 
concentration >75 nmol/L based on the available evidence with the daily intake of 
1500–2000 IU in order to achieve optimal benefits for skeletal and non-skeletal 
health [29, 30]. Accordingly, the Canadian Pediatric Society suggested 75 nmol/L as 
“sufficient” for pregnant and lactating women [31]. Moreover, several pilot stud-
ies have recommended that daily intake of 2000 [32], 4000 [33], or even 6400 IU 
[34] vitamin D would reduce vitamin D inadequacy without any toxicity sign in 
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pregnant women and their infants. The discrepancies in some factors, including 
different measurement tools of vitamin D levels, various patient populations and 
different sample sizes that were used in studies, might explain the differences in 
the recommendations. Because of conflicting evidences, identifying sufficient and 
upper-limit amount of vitamin D for pregnant women requires further research to 
be performed.
4. Maternal vitamin D status and adverse pregnancy outcomes
Numerous studies have reported pleiotropic role of vitamin D in pregnancy. 
Maternal Hypovitaminosis D during pregnancy is related to pregnancy related 
disorders. Complications caused by low serum measurement of 25(OH)D include 
gestational hypertension (GHT), PET, gestational diabetes mellitus (GDM), timing 
and mode of delivery, postpartum depression or anxiety, bacterial vaginosis, and 
other outcomes such as anemia and lipid disorders, which are discussed in this 
section.
It should be noted that, there is not enough evidence to support a recommenda-
tion for screening all pregnant women for vitamin D deficiency but must be at least 
20 ng/ml (50 nmol/L) for bone health [35]. Although some experts suggest vitamin 
D serum level of at least 32 ng/ml (80 nmol/L) for optimal state in pregnancy 
[36], some adverse effects have been reported at levels exceeding 70 nmol/L [37]. 
Consequently, due to the lack of standardized measurement procedures, there is no 
consensus on the optimal vitamin D status during pregnancy.
4.1 Gestational hypertension and preeclampsia
Elevated blood pressure that appears after 20 weeks without proteinuria or other 
findings is called gestational hypertension (GHT). This problem is confirmed by 
systolic blood pressure (SBP) ≥160 or diastolic blood pressure (DBP) ≥110 mmHg 
for anyone (confirmed over a few minutes) or SBP ≥140 or DBP ≥90 mmHg after 
20 weeks (confirmed over 4 hours) observing for the first time [38]. At least 25% 
of women with GHT is predisposed to PET [38]. PET is diagnosed by high blood 
pressure (systolic blood pressure >140 mmHg, diastolic blood pressure >90 mmHg) 
after 20 weeks of gestation along with proteinuria (>300 mg/day) and other organ 
dysfunction including liver involvement, hematological disturbance, neurological 
Agency Countries 25(OH)D threshold (nmol/L) Vitamin D intake 
(μg/d)
Deficiency Population 
average
Individual 
target
EAR RI AI
IOM [1] USA/Canada <30 40 ≥50 10 15 —
NORDEN 
[24]
Nordic <30 — ≥50 7.5 10 —
SACN [25] UK <25 — ≥25 — 10 —
EFSA [26] EU — — ≥50 — — 15
25(OH)D, 25-hydroxyvitamin D; EAR, estimated average requirement; RI, recommended (individual) intake; AI, 
adequate intake; IOM, Institute of Medicine; NORDEN, Nordic Council of Ministers; SACN, Scientific Advisory 
Committee on Nutrition; EFSA, European Food Safety Authority. Table adapted from Kiely et al. [27].
Table 1. 
Summary of the current dietary recommendations for vitamin D in pregnant women.
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or renal complications [39]. The pathogenesis of PET involves releasing the angio-
genic factors to the maternal circulation which causes insufficient remodeling 
and trophoblastic invasion of spiral arteries. It leads to shallow implantation and 
hypoxia, and even release of inflammatory mediators [40]. PET is a multifacto-
rial outcome that has not been fully understood yet; however, maternal calcium 
status is suggested to be an important factor. Therefore, vitamin D due to its role 
in calcium hemostasis might have an impact on PET [41]. In addition, vitamin D 
can be protective of placental vasoconstriction and consequently, PET because of 
its immunomodulatory effect. Also, vitamin D is a regulator of endothelial and 
vascular smooth muscle cell proliferation through which regulates blood pressure 
via Renin-Angiotensin-Aldosterone system (RAAS) [42].
Systematic reviews and meta-analysis, including cross-sectional, longitudinal, 
cohort, ecological, and observational studies, indicate inconsistent results regard-
ing the association between vitamin D deficiency and PET. Some studies reported 
an increased risk of PET women with vitamin D deficiency in pregnancy in contrast 
with others [43–45]. This contradiction of finding can be explained by different 
vitamin D assessment methods, criteria applied to define vitamin D deficiency, dif-
ferent season and trimester in studies [44]. Therefore, associations are inconclusive, 
often contradictory, confounded, and lack causality. In addition, supplementation 
helps to raise the level of maternal vitamin D; however, there is no significant 
reduction of PET risk with a higher level of vitamin D status [22, 46]. In this regard, 
more observational and interventional studies with different designs are needed.
4.2 Gestational diabetes mellitus (GDM)
Gestational diabetes mellitus (GDM) is glucose intolerance developed or first 
diagnosed during pregnancy. Criteria for recognition GDM are controversial [47]; 
according to World Health Organization (WHO), fasting blood glucose above 
92–125 mg/dl and/or 2-h glucose greater than 153–199 mg/dl after glucose intake of 
75 g are considered as diabetes mellitus in pregnancy as is a random plasma value of 
above 200 mg/dl with diabetes symptoms [48, 49]. Vitamin D plays a crucial role in 
glucose homeostasis through several mechanisms. The first is regulating calcium, 
which is a regulator for the production and secretion of insulin by the endocrine 
pancreas. Its second role involves enhancing insulin sensitivity of the target cells in 
adipose tissues, liver, and skeletal muscles. Moreover, the immune cell regulation 
role of vitamin D protects β-cells from damaging and improves its function [50, 51]. 
Although vitamin D deficiency can be associated with the pathogenesis of diabetes 
mellitus type 1 and type 2, its role in GDM is not conclusive [43]. Conflicting results 
have been found in case-control, prospective cohort studies, and reviews looking 
into the risk of GDM with vitamin D status [46]. Some review studies indicate that 
pregnant women with significant lower 25(OH)D had a higher risk of GDM by 
40–60% [45, 52], while in systematic and critical reviews, most studies failed to 
support the association between vitamin D status and GDM prevention [43, 44]. 
Thus, more large-scale prospective studies are needed to evaluate this association.
4.3 Postpartum depression (PPD) or anxiety
Depression after delivery is a common psychiatric condition which is called 
postpartum depression (PPD) [53]. Vitamin D as a neurosteroid suggested having 
a role in various brain functions and depression by several potential mechanisms. 
Firstly, Vitamin D plays as a neurotransmitter, neuro-immunomodulation, and 
neuroprotection in the brain [54]. Secondly, vitamin D has a role in synthesiz-
ing norepinephrine and dopamine, which are involved in mood disorders. 
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Furthermore, vitamin D protects the brain from oxidative stress by preserving the 
antioxidant glutathione in the brain [55, 56]. Most studies suggested there is an 
inverse association between vitamin D serum in different stages of gestation and 
postpartum depression [57–59]. In contrast, some studies indicate no association 
[60, 61], and even increased risk of PPD with sufficient vitamin D concentrations 
(≥50 nmol/L) [62]. However, in a systematic review study, a few studies reported 
the role of vitamin D in this pregnancy outcome [44]. Thus, although postpartum 
depression might be associated with vitamin D deficiency, inconsistent results need 
for more extensive studies in this regard.
4.4 Bacterial vaginosis (BV)
Bacterial vaginosis (BV) is a common vaginal infection in women in reproduc-
tive ages caused by the replacement of normal vaginal flora for mixed anaerobic 
bacteria [63]. Women diagnosed with BV are more likely to have preterm delivery 
[64]. Evidence indicates that vitamin D deficiency is an independent risk factor for 
bacterial vaginosis in pregnancy [65], and in several systematic reviews and meta-
analysis articles, this association has been reported [5, 52, 55, 66]. The risk of BV 
increases from 3- to 5-fold for serum 25(OH)D values <75 to <30 nmol/L, respec-
tively [67–69]. Therefore, several cross-sectional and observational studies con-
sistently stated the plausible inverse association between vitamin D status and BV 
during pregnancy. A possible mechanism is related to immune responses regulated 
by calcitriol. In fact, as mentioned above, vitamin D activates potent antimicrobial 
peptide hCTD, an active peptide with broad-spectrum antimicrobial activity, in the 
placenta, macrophages and dendritic cells, inducing the innate immune responses 
[70]. These findings indicate that adequate vitamin D levels are crucial to enhance 
immunity, especially in pregnancy.
4.5 Preterm delivery
Preterm delivery is defined as birth completed before 37 weeks gestation [71]. 
Infection is the most common factor in preterm delivery [72]. Vitamin D plays as 
an anti-inflammatory and immunomodulatory factor, enabling to reduce the risk 
of preterm delivery in several plausible ways. One mechanism involves response 
reduction to microbial pathogens via cancelation of IL-1, IL-6, and TNF-alpha 
production by macrophages [73]. Uterine immune cells, such as dendritic cells, 
macrophages, and natural killer cells are modulated by vitamin D [74], and vitamin 
D receptors are expressed in the ovary, endometrium, and myometrium to maintain 
reproductive health [75].
There are conflicting findings regarding the effect of Vitamin D on preterm 
delivery. Some articles including critical and narrative reviews, reported no asso-
ciation between vitamin D deficiency and preterm delivery [43, 46, 76, 77], while 
single studies, systematic review, and meta-analysis showed significant relationship 
between them [45, 78–81]. Inconsistent findings can be explained by different 
designs of each study including the timing of 25(OH)D assessment, and different 
definition of preterm delivery. For instance, in two studies, ≤35 weeks gestation for 
preterm delivery was considered [78, 82], while in another study it was <37 weeks 
gestation [77].
Ethnicity appears to be an important factor regarding preterm birth. Bodnar 
et al. reported that the risk of preterm delivery increased only in non-white mothers 
compared to white women [82]. In a cohort study by Wagner et al., Hispanic women 
with serum 25(OH)D > 40 ng/ml had 79% reduced risk of preterm birth in com-
parison with those with serum 25(OH)D ≤ 20 ng/ml, while the reduced risk was 
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45% among black women [83]. Also, an increased risk of preterm birth associated 
with Vitamin D insufficiency in ethnic minority women in Canada [84] suggests 
the stratification of women based on their ethnicity in further studies. Another 
important thing should be considered in study design is the association of vitamin 
D status in different gestational age with pregnancy outcome. For instance, one 
study suggested that maternal vitamin D status closest to delivery time was the best 
indicator for preterm birth because of the more significant reduced risk in the third 
semester compared to serum concentrations of vitamin D in the first and second 
semesters [85]. Thus, vitamin D deficiency is likely to be associated with preterm 
birth, nevertheless, to investigate the explicit relationship between vitamin D 
status and preterm delivery several factors should be noted including the timing of 
25(OH)D assessment (first, second, or third trimester), ethnicity, precise definition 
of preterm birth, different study design such as human interventional and cohort 
studies.
4.6 Cesarean delivery
Uterine muscle and skeletal muscle cells have VDR, which is a regulator of the 
contractile proteins of uterine myometrial cells [86]. Therefore, the strength of the 
contractile muscles is decreased with vitamin D deficiency as well as malformation 
of the pelvis, which are indications for C-section [87]. The indication of C-section 
can be related to vitamin D deficiency, but there is a mixture of results regard-
ing this association. For example, prospective cohort studies suggested there was 
an inverse association with having a cesarean section and serum 25(OH)D levels 
[88–90], whereas others did not support this relationship [76, 87, 91]. Regarding 
ethnicity, in a cohort multi-ethnic Asian study, vitamin D deficiency was related 
to a higher risk of C-sections in Chinese and Indian women compared to Malay 
women [86]. Factors such as the different definition of C-section in terms of indica-
tion, primary or secondary, emergency or elective might be the reason of inconclu-
sive findings [91]. Although observational studies mentioned above investigated 
a possible relationship between vitamin D and cesarean delivery, more studies are 
needed to verify this association along with biological and geographical factors.
4.7 Recurrent pregnancy losses (RPL)
Recurrent pregnancy losses (RPL) and repeated implantation failures (RIF) are 
two auto- and cellular immune abnormalities, and vitamin D deficiency is prevalent in 
women with RPL and RIF. Vitamin D plays a pivotal role in the regulation of auto- and 
cellular immune disorders [92]. Studies reported that 45% of RPL patients had vitamin 
D deficiency in one study, and increased risk of first-trimester miscarriage and recur-
rent pregnancy losses (RPL) was found with vitamin D insufficiency [93, 94]. Even 
this association has been found in early spontaneous pregnancy loss [95]. Studies show 
an inverse association between vitamin D deficiency and RPL; however, no conclu-
sion can be drawn based on the findings of a few studies and more observational and 
interventional studies are necessary to confirm such association [43].
4.8 Other related outcomes
Other outcomes including spontaneous abortion [77, 96, 97] and stillbirth 
[77, 96], short gestational length [98], and low Apgar score [76, 96, 98] were not 
associated with vitamin D insufficiency, according to a systematic review and meta-
analysis of longitudinal studies [99]. However, more studies with different designs 
such as clinical trials are necessary. Anemia, lipid disorders, periodontal disease, 
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and HIV-related mortality are other pregnancy implications related to vitamin D 
deficiency. There is a mixture of results with regard to the vitamin D deficiency 
and anemia in pregnancy. Some studies indicated this relationship [100], while 
other studies failed to support it [76, 101]. The findings show a positive correlation 
between serum vitamin D and atherogenic factors such as total cholesterol and 
triglycerides [102, 103]. As vitamin D has immunomodulatory effects, it may have a 
protective role against mother-to-child transmission (MTCT) of the human immu-
nodeficiency virus (HIV). A study on HIV-infected pregnant women conducted 
in Tanzania found that low maternal vitamin D level (<32 ng/mL) at 12–27 weeks 
gestation was associated with a 50% higher risk of MTCT of HIV [104]. Moreover, 
vitamin D insufficiency (serum 25[OH]D < 75 nmol/l) was associated with mater-
nal periodontal disease during pregnancy, as reported by Boggess et al. [105].
Almost all the pregnancy complications related to vitamin D deficiency were 
discussed in this section. However, the results were contradictory due to small study 
samples in some studies, cross-sectional design, lack of adjustment for seasonal 
variation, race and ethnicity, various study design in terms of the trimester (first, 
second, or third trimester), different definition of some outcomes and even cut 
points to categorize vitamin D status. These inconsistencies justify the need for 
more large-scale prospective studies and interventional studies to evaluate these 
associations comprehensively.
5. Maternal vitamin D status across different ethnic groups
Vitamin D deficiency has been reported among pregnant women globally, 
particularly among ethnic minorities and white women residents at high latitude 
[106]. Ethnic variety in vitamin D status of pregnant women can be relevant to large 
disparities in skin color, vitamin D intake, religion, culture, sun exposure (seasonal 
variation), and geographical location [107]. In ethnic minorities, the prevention 
of vitamin D deficiency on a population basis is challenging due to the shortage of 
clarity surrounding the metabolism and transport of vitamin D [108]. Due to lack 
of enough evidence regarding the nutritional requirements for vitamin D during 
pregnancy, there is no pregnancy-specific dietary recommendation for vitamin 
D. In addition, the question of specific dietary reference setting specifically for each 
ethnicity (for pregnant women) has not been addressed to date [109].
The best indicator of vitamin D status is the serum 25(OH)D concentration, 
because it is not regulated, and reflects both dietary intake and synthesis form of 
vitamin D [110]. However, there is no absolute agreement on normal range of vitamin 
D, although most authors have consensus that serum 25(OH)D concentration should 
be ≥50 nmol/L [110–112]. Ethnic differences in vitamin D status are in accordance 
with the ethnic differences in circulating vitamin D, where a mean value of 57 nmol/L 
has been reported for Caucasian pregnant women in Canada [113], a median value 
of 53 nmol/L has been reported for Belgian women [114], 57 nmol/L has been 
reported for pregnant women in Australia [115]. A cohort study in 2011 indicated 
that the mean 25(OH)D level in African-Americans was 38.75 nmol/L, Hispanics was 
60.25 nmol/L, and Caucasians was 72.5 nmol/L [116]. African-American pregnant 
women had the lowest serum 25(OH)D in this study. However, in Southern Europe, 
Morales et al. demonstrated a median plasma value of 25(OH)D in pregnancy of 
73.88 nmol/L [117]. Furthermore, a recent systematic review reported that mean 
25(OH)D levels in the general populations were higher in America (North America) 
(75 nmol/L) than in the Middle East (50 nmol /L) or Europe (52 nmol/L) [118].
The absence of race- and pregnancy-specific dietary recommendations 
places pregnant women of the ethnic minority among the most vulnerable and 
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under-investigated population groups concerning vitamin D [106]. A review study 
indicated that pregnant women in Latin America, Asia, the Middle East, and Africa 
are at the danger of vitamin D deficiency and these are known as the topmost 
universally locations for occurrence of vitamin D deficiency and reported that 
incidence of vitamin D deficiency varied from 51.3 to 100% [119]. Recent studies 
in the United States, Canada, Australia, Iran, Sweden, and Pakistan reported that 
the range of vitamin D deficiency and insufficiency were 24–95.8% and 54–100% 
among pregnant women [116, 120–125]. The evidence for racial differences in 
vitamin D deficiency (Table 2) indicated that the global prevalence of 25(OH)D 
concentrations <50 nmol/L is 54% among pregnant women and 75% among new-
borns [106]. In other words, one in five pregnant women (18%) and one in three 
newborns (20%) had serum vitamin D concentration <25 nmol/L, which is a public 
health concern [106]. Vitamin D status is poorly defined in the South-East Asian, 
African, and Eastern Mediterranean regions and the non-European population in 
the Western Pacific region (Table 2) [106].
Maternal vitamin D deficiency is also investigated for each trimester across 
different regions and ethnicities. For instance, in Thai pregnant women, high 
prevalence of vitamin D deficiency and inadequacy were reported in the first 
trimester: 26.7% (<50 nmol/l) and 56.7% (<75 nmol/l), respectively. Then, vitamin 
D inadequacy decreased to 30.9% (1.8% deficiency) in the second trimester and 
27.4% (2.8% deficiency) in the third trimester [120]. Pregnant women were studied 
in the first trimester of pregnancy (gestational week 11–14) living in Mediterranean 
seacoast at latitude 36°N, therefore at a high sun exposure area, were classified as 
Spanish Caucasians and Arab immigrants [121]. The median serum 25(OH)D  
concentration for the whole sample was 68.39 nmol/L. Only 35.9% of the par-
ticipants had adequate serum 25(OH)D concentrations (75 nmol/L), while these 
concentrations were found to be inadequate (50–75 nmol/L) in 41.4% and deficient 
(<50 nmol/L) in 22.7% of respondents. Vitamin D status was lower in Arab women 
in comparison to Caucasian women [121]. Another study reported that in second 
trimester 40.7% (<50 nmol/L) of Chinese pregnant women who lived at their urban 
locations had vitamin D deficiency [122]. According to a cross-sectional study in 
China, 74.9% of Chinese pregnant women had vitamin D shortage (25-hydroxyvi-
tamin D < 50 nmol/L) [123]. In one of the National Health and Nutrition 
Examination Survey (NHANES) studies reported that among different factors, the 
largest magnitude of association was observed between race and 25(OH)D status. 
Those who were non-Hispanic whites in third trimester had a higher vitamin D 
levels (93 nmol/L) than non-Hispanic black (45 nmol/L) or Hispanic (69 nmol/L). 
WHO regions Percentage of 25-hydroxyvitamin D deficiency
% < 25*(nmol/L) % <50** (nmol/L)
Americas 64 9
European 57 23
Eastern Mediterranean 46 79
South-East Asian 87 N/A***
Western pacific 83 13
Adopted by Saraf et al. [106]. 
*Vitamin D deficiency.
**Severe vitamin D deficiency.
***Not available.
Table 2. 
Prevalence of maternal vitamin D deficiency classified by WHO region.
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Vitamin D insufficiency in this study was 13%, 54% among whites, 80%, 95% 
among blacks, and 45%, 83% among Hispanics for 25(OH)D concentrations <50 
and <75 nmol/L, respectively [124]. A recent cohort study reported that 44% of 
non-European pregnant women in the Netherland had vitamin D deficiency com-
pared to European ones either with maternal serum or cord blood [125]. While from 
one of the Persian Gulf countries (United Arab Emirates (UAE)), 69% of vitamin D 
deficiency was reported among pregnant women [126].
Generally, previous recommendations have indicated that winter, higher 
latitude, dark pigmentation, season, limited sun exposure, and dressing style as 
risk factors for vitamin D deficiency. It can be difficult to describe the prevalence 
of pregnant women at risk to vitamin D deficiency because vitamin D status varies 
according to how deficiency is defined, as well as aforementioned risk factors 
[127–129]. These studies indicated that despite the geographical location of each 
region, vitamin D deficiency is highly prevalent among pregnant women because of 
the lifestyle and nutrition status of mothers. Future studies are required to investi-
gate vitamin D deficiency of pregnant women among different ethnic groups based 
on similar cut-off values for vitamin D deficiency.
As we discussed in Section 4, vitamin D deficiency has a key role in the develop-
ment of PET and GDM. In this section, we elaborate on the differences that the 
occurrence of these two diseases might have among different ethnic groups.
5.1 PET and GDM among ethnic disparities
Pregnant minorities have been the least studied in vitamin D-related diseases 
such as PET and GDM. According to a meta-analysis, the occurrence of PET is 
seen at lower vitamin D levels due to the immunomodulation properties of vita-
min D [52]. A recent study examined the evidence linking vitamin D deficiency 
in pregnancy to PET among different ethnic groups. Although prevalence of 
vitamin D deficiency differed significantly among African-Americans (72.3%), 
Hispanics (10.6%), and Caucasians (2.1%), there were no direct associations 
between low 25(OH)D levels and risk for PET among different ethnic groups 
[130]. While another recent study in UK indicated a greater prevalence of white 
British women developed GHT (12.0%) and PET (3.4%), compared to Pakistani 
women (the proportion of GHT and PET were 5.4 and 1.7%, respectively) [131]. 
The heterogeneity that exists among studies in terms of sun exposure (naturally 
occurring vitamin D synthesized from), geographical locations, considering 
different ethnic groups with divergent cultures, may lead to the differences in 
results.
It has been shown that maternal vitamin D concentration has inversely been 
linked to impaired glucose metabolism in pregnancy [132]. A few studies consid-
ered the effect of ethnicity on this relationship in pregnancy such as Clifton et al. 
study in Australia, which examined the association between serum 25(OH) D 
with GDM among five different ethnic groups including European (European 
Australian, English, German, Spanish), South-East Asian (Chinese, Japanese, 
Korean, Indonesian, Thai, Malaysian), Asian (Indian, Pakistani, Bangladeshi, Sri 
Lankan), Middle Eastern (Iranian, Iraqi, Lebanese, Syrian), and Other (Aboriginal 
Australian, Samoan, Papua New Guinean). They found no significant association 
between 25(OH)D and GDM in any ethnic group [132]. Generally, ethnicity was not 
an independent predictor of insulin resistance.
Overall, well-designed prospective cohort studies are needed to inform and 
update our knowledge regarding vitamin D deficiency and its association with PET 
and GDM among different ethnic minorities.
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5.2 Latitude
Sun exposure decreases dramatically, with increasing latitude [129]. It seems 
logical that higher latitudes would report a higher proportion of vitamin D defi-
ciency like Northern European countries, in comparison to the European South. 
In addition, almost all European Mediterranean countries are located at a high 
latitude (37–38°N), and previtamin D3 photosynthesis is lower during winter. 
Similar or even smaller proportion of vitamin D deficiency among pregnant women 
was reported from countries with higher latitudes in Western and Central Europe 
(latitudes 46–81°N) [133]; Slovenia with 46.5°N latitude, showed a high prevalence 
of severe vitamin D deficiency (23.6% with the threshold of <25 nmol/l) among 
pregnant women [134]. Even if in lower latitudes, the prevalence of maternal 
vitamin D deficiency is still high such as a study in China demonstrated that over 
90% of pregnant women in urban northern China (39.9°N), had vitamin D defi-
ciency (<50 nmol/l) and none had normal 25(OH)D concentrations (≥75 nmol/L) 
[135]. Although the Goulburn Valley in Northern Victoria (Australia) experiences 
abundant sunshine and located at 36° South of the equator, a place where vitamin 
D synthesis is possible during the year, 49.4% of pregnant women (<75 nmol/l) 
had vitamin D inadequacy and 12.2% (25–50 nmol/L) of pregnant women had a 
mild deficiency and 3.2% (<25 nmol/l) suffered a moderate/severe deficiency in 
summer [136]. A recent study from Bangkok, Thailand also revealed that 23.3% 
of Thai pregnant women had vitamin D deficiency in fall and 44.6% in winter 
(<50 nmol/L), despite the fact that this city is located at 13.45 N latitude and 
benefits sunlight throughout the year [137].
Over the past few decades, several studies have reported a high prevalence of 
maternal vitamin D deficiency in countries where women wear concealing cloth-
ing such as India (31%) [138], Saudi Arabia (14.2%) [139], and Iran (5.7%) [140] 
and countries in northern latitudes such as the United Kingdom (21.2%) [141] and 
Norway (33% deficiency and 18% severe deficiency across three ethnic groups) 
[142]. Due to less sunlight exposure, these pregnant women are at high risk of 
vitamin D deficiency. The duration of sun exposure is directly associated with the 
concentration of 25(OH)D [135, 138]. Mothers with less than 0.5 h/day of sun expo-
sure had a higher prevalence of vitamin D deficiency (38.4%) in China, which would 
worsen the situation in winter that the tendency toward outdoor physical activity 
decrease among pregnant women [135]. However, in sunny regions like Turkey, 
vitamin D deficiency among pregnant women is still a serious problem with the 
prevalence of 90% [143]. In addition, the prevalence of vitamin D deficiency (48%) 
was noted among pregnant women in South Carolina at latitude 32°N, where women 
lived in a sun-rich climate for most of the year [144]. Despite the longer duration 
of sunlight in UAE (ranges from 9 to 11 h), 69% of pregnant women suffer from 
vitamin D deficiency. It can be due to the decrease in time spent on outdoor activities 
and to the dressing style, which limits the surface area exposed to the sun [126].
Overall, latitude is an important factor but the other factors such as culture, 
belief, indoor lifestyle, etc., would play key roles in vitamin D deficiency in sun-rich 
countries.
5.3 Skin pigmentation
Skin pigmentation is the main determinant of ultraviolet B-rays (UV-B) absorp-
tion in humans [129]. The absorption of UV-B would be more when the skin is 
pale compared with the darker skin. In other words, the probability of vitamin D 
deficiency would be higher when skin pigmentation increases in critical periods 
Vitamin D Deficiency
12
like pregnancy [126]. Pregnant women who live in southern Europe have more 
pigmented skin, probably with less efficient vitamin D synthesis [145]. In Italy, 
vitamin D deficiency of pregnant women (with different ethnic groups) was 
examined based on their skin color (fair, black, light brown). It was found that 22% 
had severe vitamin D deficiency (<25 nmol/L) in total and fair-skinned mothers 
had higher 25(OH)D concentrations [146]. Another study in Netherland observed 
several ethnic backgrounds who reside in The Hague in the Netherlands (52°N), 
that vitamin D deficiency is more common among most non-Western participants 
(dark-skinned) (59–84%) compare to western women (fair-skinned) (8%) [147]. In 
southwestern Sweden, vitamin D deficiency was examined among pregnant women 
from different backgrounds with various skin colors. The prevalence of vitamin D 
deficiency was 10% overall, and 2% among mothers born in north Europe, while 
vitamin D deficiency among women born in Africa was 50% (<30 nmol/L) and 
deficiency was common among Asian mothers as well [148]. A recent US study 
reported in the multi-ethnic population of pregnant women in the southeastern 
USA, non-Hispanic black pregnant women are most at risk for vitamin D insuf-
ficiency (91%) compare to non-Hispanic white women (47%) and Hispanic women 
(75%) [149]. The concentration of melanin in the skin determines vitamin D 
production. Melanin, which absorbs UV-B in the 290–320 nm range, functions as 
a light filter and therefore regulates the proportion of the vitamin D production 
[150]. Thus, skin pigmentation is a dominant variable controlling the production 
of vitamin D under circumstances of low levels of sun exposures because melanin 
absorbs UV photons in competition with 7-dehydrocholesterol [151, 152]. Overall, 
darker-skinned pregnant women need a greater duration of sun exposure (4–5 
times) (they are more at risk in higher latitudes) in comparison to light-skinned 
ones to provide a comparable amount of vitamin D [153].
6. Maternal vitamin D status and fetal and postnatal outcomes
A growing body of evidence suggests that maternal vitamin D deficiency is 
associated with not only pregnancy outcomes, but also later physical and mental 
health of the offspring. In this section, we aim to review the existing literature 
investigating the impact of maternal vitamin D status during pregnancy on a range 
of fetal and postnatal outcomes.
6.1 Fetal skeletal development
During pregnancy, the fetus relies on maternal supply and placental delivery of 
vitamin D and calcium for optimal development and function, particularly of the 
skeletal system [154]. Maternal vitamin D deficiency during pregnancy predisposes 
breast-fed infants to neonatal hypocalcemia and infantile rickets [155, 156]. It has 
been reported that maternal UV-B exposure in pregnancy is related to bone mineral 
content (BMC) and bone mineral density (BMD) at age 9.9 years independently of 
height and lean mass [157]. Further, winter newborns in Korea were found to have 
6% lower total body BMC, lower cord serum 25(OH)D and 1,25-dihydroxyvitamin 
D than summer newborns [158]. These results suggest that low maternal vitamin D 
concentrations due to limited UV-B exposure may exert direct effects on offspring 
bone mineral accrual.
The influence of maternal vitamin D status on bone outcomes has been investi-
gated in several observational studies at fetal [159–161], postnatal [162–164], and 
adult stages [115, 165–167]. Using data from a prospective longitudinal study, Mahon 
et al. observed that lower maternal 25(OH)D concentration was associated with the 
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greater femoral metaphyseal cross-sectional area at 19 weeks gestation and 34 weeks 
gestation. However, lower maternal 25(OH)D concentration was not related to fetal 
femur length [159]. In another prospective longitudinal study, Young et al. found a 
significant positive association between maternal 25(OH)D levels and fetal femur 
and humerus z-scores only when maternal calcium intake was <1050 mg/d [160]. It 
has also been reported that maternal serum 25(OH)D concentration, together with 
maternal height and adiposity, was significant predictors of femoral size [161]. In a 
cross-sectional study with a longitudinal follow-up, tibia BMC was 0.047 g/cm higher, 
and cross-sectional area was 12.3 mm2 larger in newborns with the first trimester and 
cord serum 25(OH)D above the median (42.6 nmol/L) compared with below median 
newborns [162]. In another study, Morley et al. found smaller knee-heel length in 
infants of mothers with low 25(OH)D levels (<28 nmol/L) in late pregnancy (28–
32 weeks of gestation) compared to babies whose mothers had higher concentrations 
[163]. Dror et al. reported no association between feto-maternal vitamin D status and 
early infant whole-body BMC. However, a large percentage of mothers in their study 
had adequate vitamin D status, which may have affected the results [164]. These 
observations suggest that maternal vitamin D status during pregnancy can influence 
fetal bone growth as early as the second trimester of pregnancy.
Emerging evidence suggests that the relationships between maternal vitamin 
D status and bone outcomes persist into childhood and beyond [115, 165, 166]. 
In a longitudinal study by Javaid et al., it was found that reduced concentration 
of maternal 25(OH)D during late pregnancy was associated with reduced whole-
body and lumbar-spine BMC in children at age 9 years. Besides, childhood bone 
mass was predicted by maternal use of vitamin D supplements and the estimated 
exposure to UV-B radiation during late pregnancy [165]. Zhu et al., in a study of 
341 mother and offspring pairs, found a positive association between maternal 
25(OH)D concentration and total body BMC and BMD in offspring at 20 years of 
age [115]. These results were confirmed in another study where maternal vitamin 
D deficiency (25(OH)D < 50 nmol/L) during pregnancy was associated with lower 
peak bone mass at 20 years [166]. In contrast to these studies, Lawlor and colleagues 
observed no relevant association between vitamin D deficiency in pregnant women 
and offspring’s BMC in late childhood [167]. In another study, compared to children 
born to mothers with high vitamin D status, tibial BMC was lower at birth in chil-
dren with low maternal vitamin D status, while BMC gain was greater, resulting in 
similar BMC at 14 months [168]. The evidence derived from observational studies, 
although conflicting, tends to suggest an association between vitamin D deficiency 
in pregnant women and reduced bone mineral accrual in the offspring, which may 
increase fracture risk in later life.
6.2  Birth anthropometry, small-for-gestational-age (SGA), and childhood 
growth
There is controversy regarding the relationship between maternal vitamin D sta-
tus and neonatal birth weight, with some studies reporting an association between 
reduced maternal vitamin D levels and lower neonatal birth weight [169–174], and 
others showing no association [175–178]. While some studies found no association 
between maternal vitamin D levels and other anthropometric birth outcomes such 
as length and head circumference [176–179], others suggested a nonlinear relation 
between 25(OH)D levels and head circumference [171, 174].
Inconsistencies in the literature have led several researchers to conduct 
meta-analyses to further clarify the association between maternal vitamin D 
concentrations and anthropometric outcomes in offspring. Four meta-analyses 
of observational studies have been published in recent years [45, 52, 180, 181]. In 
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the first study, Wei et al. carried out a meta-analysis on six studies and found that 
pregnant women with circulating 25(OH)D levels less than 50 nmol/L experi-
enced an about 1.5-fold increased risk of SGA [45]. These results were confirmed 
in another meta-analysis of 13 prospective cohort studies, in which a significant 
positive association was found between maternal vitamin D deficiency and risk of 
SGA infants (pooled odds ratio 1.58; 95% CI 1.14–2.22) in the random effects model 
[180]. Similar results were obtained in subgroup analyses by study quality (high vs. 
low), gestational week for blood sampling (first trimester vs. second trimester vs. 
mixed), cut-off vitamin D levels (<10 ng/mL vs. <15 ng/mL vs. <20 ng/mL), sample 
size (N > 1000 vs. N < 1000), adjustment for critical confounders (Yes vs. No), and 
method for measuring vitamin D (liquid chromatography with tandem mass spec-
trometry vs. others) [180]. There results suggest that maternal vitamin D deficiency 
may be associated with an increased risk of SGA infants.
A meta-analysis conducted in 2013 showed that insufficient serum levels of 
25(OH)D in pregnant women was associated with increased risk of having SGA 
infants (pooled odds ratio 1.85; 95% CI 1.52–2.26) [52]. In terms of birth weight, 
the authors used data from four observational studies and found infants of moth-
ers with low 25(OH)D concentrations during pregnancy (<37.5 nmol/L) had 
lower birth weight (random weighted mean difference −130.9 g). However, no 
significant difference was observed between maternal vitamin D status and other 
anthropometric outcomes such as birth length and head circumference [52]. The 
most recent meta-analysis conducted by Tous et al. included 54 eligible stud-
ies and reported that vitamin D-deficient mothers (<30 nmol/L) had offspring 
with lower birth-weight (mean difference −87.82 g), head circumference (mean 
difference −0.19 cm), and a higher risk of SGA infants (odds ratio 1.59; 95% CI 
1.24–2.03) compared to mothers with concentrations ≥30 nmol/L. However, no 
difference was observed in terms of infants’ length [181]. The results also revealed 
a significant association between vitamin D insufficiency (<50 nmol/L) and 
increased risk of SGA (odds ratio 1.43; 95% CI 1.08–1.91). The authors found no 
significant differences in birth-weight and SGA between offspring born to moth-
ers with 25(OH)D concentrations <75 nmol/L and those born to mothers with 
25(OH) D concentrations ≥75 nmol/L [181]. Further, a meta-analysis of 13 inter-
ventional studies revealed that vitamin D supplementation during pregnancy was 
associated with significantly higher circulating 25(OH)D levels (mean difference: 
66.5 nmol/L), birth weight (mean difference: 107.6 g), and birth length (mean 
difference: 0.3 cm), when compared to the control group [182]. Neonates exposed 
to low levels of vitamin D in utero (<30 nmol/L) showed accelerated growth in 
length and weight during the first year of life to compensate for their small initial 
size [183, 184]. There results suggest that maternal vitamin D deficiency is associ-
ated not only with increased risk of SGA infants but also with lower birth-weight. 
However, more studies are required to draw a firm conclusion on the relationship 
between maternal vitamin D status and other anthropometric outcomes.
6.3 Offspring soft tissue body composition
A growing body of evidence suggests that maternal vitamin D status in preg-
nancy may play a part in the offspring adipogenesis [185–189]; however, not all 
studies are in agreement [190, 191]. Tint et al. conducted a study to examine the 
association between maternal 25(OH)D status at mid-gestation and neonatal 
abdominal adipose tissue (AT) compartments. The findings indicated an inverse 
liner correlation between maternal 25(OH)D and both superficial and deep sub-
cutaneous AT compartments measured by magnetic resonance imaging (MRI). 
In addition, compared to neonates born to mothers with 25(OH)D sufficiency 
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(>75.0 nmol/L), neonates with maternal 25(OH)D inadequacy had higher superficial 
and deep subcutaneous AT volumes, despite similar birth weight [185]. However, 
in a prospective observational study, Godang et al. reported a positive association 
between neonatal total body fat mass (FM) and umbilical cord plasma, but not 
maternal, 25(OH)D [190]. This was confirmed in another study where a positive 
correlation between cord blood 25(OH)D levels and neonatal percentage body fat 
was observed [192]. Using data from the Southampton Women’s Survey, Crozier 
et al. found that lower maternal vitamin D status at 34-week gestation was associated 
with lower FM in the offspring at birth but with greater FM at ages 4 and 6 years 
[186]. Similarly, a prospective pregnancy cohort conducted by Daraki et al. showed 
that offspring of mothers in the low 25(OH)D tertile (<37.7 nmol/L) had higher BMI 
and waist circumference at preschool age, compared with the offspring of women 
with higher 25(OH)D concentrations, and this relationship persisted at age 6 years 
[187]. Results from a recent prospective cohort conducted in 476 mother/infant 
dyads also demonstrated that reduced maternal 25(OH)D (first quartile compared 
to the fourth quartile) was associated with lower birth weight for gestational age 
z-scores (−0.43 units) but higher 1-year weight-for-length (0.78 units) and 3-year 
BMI z-scores (0.83 units) in offspring [188]. In another study, maternal deficit of 
25(OH) D (<50 nmol/L) was reported to be associated with increased risk of fetal 
overweight defined as abdominal circumference ≥90th percentile or either as the 
estimated fetal weight ≥90th percentile. Moreover, a significant association was 
found between deficit of 25(OH)D in pregnancy and increased risk of overweight 
in offspring at age 1 year. However, this association was attenuated at age 4 years 
[189]. In contrast to these studies, Ong and colleagues, in a mother-offspring cohort 
in Singapore, observed no significant associations between maternal vitamin D 
status and any of the adiposity outcomes (i.e., BMI and skinfold thickness) at birth 
or postnatally. This was partly explained by the low prevalence of severe maternal 
vitamin D deficiency in the studied population (mean maternal vitamin D concen-
tration of 81.3 nmol/L) [191]. These findings suggest that intrauterine exposure to 
low 25(OH)D concentrations may be linked to lower FM at birth but greater FM 
during childhood. A higher FM may also contribute to decreased 25(OH)D levels in 
obese individuals, partly due to the sequestration of vitamin D by AT [193].
A limited number of studies have investigated the influence of maternal vitamin 
D status on offspring lean mass or muscle strength [194, 195]. Using data from 
Mysore Parthenon Study, Krishnaveni et al. reported that Indian children born to 
vitamin D-deficient mothers (serum 25(OH)D < 50 nmol/L) had a smaller arm-
muscle area at ages 5 and 9.5 years in comparison with children born to mothers 
without deficiency. However, no difference in grip strength was observed between 
the offspring of mothers with and without vitamin D deficiency [194]. In contrast, 
a study conducted in 678 mother-child pairs showed that maternal serum 25(OH) D 
concentration in pregnancy was positively associated with height-adjusted hand 
grip strength but not muscle mass in offspring at 4 years of age [195]. These results 
suggest that low maternal vitamin D status may be associated with the smaller arm-
muscle area and lower muscle strength in the offspring. However, more observa-
tions are required to draw a firm conclusion on this matter.
6.4 Respiratory health
In humans, lung development starts in utero with the formation of two endo-
dermally derived lung buds and continues through childhood, adolescence, and 
early adulthood [196]. A growing body of evidence suggests that the origins of 
respiratory disorders such as asthma can be traced back to the fetal period when the 
lung is undergoing rapid development [197, 198]. It has been shown that vitamin D 
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is involved in the process of maturation of the fetal lung including type II alveolar 
cells maturation and the alveolarization [199]. Currently, there are four meta-
analyses published within a 3-year period from 2016 to 2018, which examined the 
association between maternal 25(OH)D levels during pregnancy and the offspring’s 
respiratory conditions [200–203]. The first meta-analysis included eight studies 
on the association between maternal vitamin D status and childhood asthma or 
wheeze. This meta-analysis showed no statistical association between maternal 
vitamin D during pregnancy and risk of childhood asthma or childhood wheeze 
[200]. In contrast, the second meta-analysis included 15 prospective studies with 
12,758 participants and found a U-shaped relationship between 25(OH) D levels 
during pregnancy and risk of childhood asthma, with the lowest risk at approxi-
mately 70 nmol/L [201]. The third meta-analysis assessed the association of both 
cord blood and maternal 25(OH)D levels with the risk of offspring’s asthma, 
wheeze, and respiratory tract infections. The results revealed borderline significant 
inverse associations between in utero exposure to vitamin D and risk of asthma 
and wheeze, but not the risk of respiratory tract infections in offspring [202]. In 
the final and most recent meta-analysis, Pacheco-González et al. found an inverse 
association between prenatal exposure to 25(OH)D and the risk of respiratory tract 
infections. The authors also observed a positive borderline association between 
maternal or cord blood 25(OH)D levels and lung function at school age. However, 
no associations were found for asthma and wheeze [203]. The apparently conflict-
ing results of meta-analyses may be partly explained by differences in inclusion 
criteria, the number of studies, the characteristics of participants and the meth-
odology used. Further, the results of two other meta-analyses revealed that higher 
maternal intake of vitamin D was associated with lower odds of wheeze during 
childhood [204, 205]. Taken together, these results suggest the role of maternal 
vitamin D status as a protective factor for the development of offspring respiratory 
disorders.
6.5 Immunity and allergies
Some studies are suggesting that low maternal or cord blood 25(OH)D con-
centrations are associated with an increased risk of developing atopic disorders, 
including atopic dermatitis or eczema, allergic rhinitis, asthma, and food allergy 
[206–209]. A study conducted in 270 mother-child pairs showed that a higher 
cord blood 25(OH)D concentration was associated with reduced risk of eczema in 
children at 1 and 3 years of age. However, no significant associations were found 
between cord blood 25(OH)D concentration and the development of allergic rhini-
tis, allergic sensitization, or asthma [206]. In another study, cord serum 25(OH) D 
levels were found to be inversely associated with the risk of atopic dermatitis by 
the age of 5 years, but no association was reported with allergic rhinitis and asthma 
[207]. Chiu et al. observed a significant association between low cord blood 25(OH)
D levels and increased risk of milk sensitization but not eczema, allergic rhinitis, 
or asthma in early childhood [208]. In another study with the same authors, it was 
revealed that lower maternal 25(OH)D levels (<20 ng/ml) were associated with 
a higher prevalence of allergen sensitization before age 2, and higher maternal 
25(OH)D levels were associated with lower risk of eczema and asthma at age 4 
[209]. Wei et al. conducted a meta-analysis of prospective cohort studies to examine 
the association between maternal vitamin D status and childhood allergic diseases. 
They found an inverse association between maternal vitamin D status during preg-
nancy and risk of childhood eczema but not childhood asthma or wheeze [200]. 
However, a recent meta-analysis of observational studies reported no significant 
associations between 25(OH)D levels in cord blood at birth or maternal blood in 
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pregnancy and the risk of atopic disorders [203]. Taken together, these studies 
indicate that lower maternal 25(OH)D concentration may be associated with an 
increased risk of developing atopic disorders.
Here, we discuss the role of intrauterine vitamin D exposure on the risk of two 
common autoimmune diseases—type 1 diabetes and multiple sclerosis. Type 1 
diabetes mellitus is an autoimmune disease characterized by the destruction of the 
insulin-producing pancreatic β-cells of the Langerhans islets [210]. Staples et al. 
found an inverse association between annual ambient UV radiation exposure and 
prevalence of type 1 diabetes in Australia, which was suggested to be due to the role 
of UV radiation in vitamin D synthesis [211]. In a case-control study conducted in 
109 cases and 219 control women, it was observed that lower levels of vitamin D 
during pregnancy were associated with a higher risk of developing type 1 diabetes 
in offspring before 15 years of age [212]. In contrast, in another case-control study 
conducted in Finnish women, Miettinen et al. found no difference between serum 
25(OH)D levels during early pregnancy between mothers whose children later on 
developed type 1 diabetes, and mothers of healthy children [213]. Thorsen and col-
leagues showed that normal variation in maternal or neonatal 25(OH)D levels has 
no significant effect on the risk of childhood type 1 diabetes [214]. Jacobsen et al. 
also failed to find an association between 25(OH)D levels around the time of birth 
and the risk of developing type 1 diabetes before the age of 18 years [215]. As these 
studies found inconsistent results, more research is still needed before any conclu-
sions can be drawn on the relationship between maternal vitamin D status and risk 
of developing type 1 diabetes in offspring.
Multiple sclerosis (MS) is an autoimmune disease, in which the immune system 
attacks the myelin sheaths surrounding nerve cells [216]. Accumulating evidence 
suggests an association between the month of birth and risk of MS [217–219], pos-
sibly due to variation in UV exposure, which in turn determines maternal vitamin 
D levels during pregnancy. In support of this hypothesis, Munger et al. reported 
that maternal vitamin D deficiency (<30.0 nmol/L) during early pregnancy was 
associated with increased risk of MS (almost 2-fold) in the offspring compared 
with women with normal 25(OH)D levels [220]. A nested case-control study 
demonstrated that exposure to high 25(OH)D levels during the years preceding 
disease onset was associated with decreased risk of MS in the offspring. However, 
no decrease in risk of MS was observed in the offspring exposed to high levels 
of 25(OH)D in utero (≥75 vs. <75 nmol/L) [221]. Nielsen et al. also carried out 
a matched case-control study and found an association between lower levels of 
25(OH)D in neonates and increased risk of MS [222]. However, in another popula-
tion-based case-control study conducted in Sweden, Ueda et al. failed to find such 
as association [223]. These results suggest that exposure to low levels of 25(OH)D 
prenatal and in early postnatal life may act as a risk factor for developing MS.
6.6 Offspring brain development and function
A growing body of evidence suggests that low maternal 25(OH)D levels during 
pregnancy are associated with impaired neurodevelopmental and neurocognitive 
outcomes during infancy and childhood [117, 224–228]; however, not all studies 
are in agreement [229, 230]. In this regard, several studies have shown a significant 
association between suboptimal maternal vitamin D status and reduced language 
developmental outcomes in the offspring [224–226].
Accumulating evidence also suggests a link between maternal vitamin D levels 
and the risk of developing neuropsychiatric disorders such as attention deficit 
hyperactivity disorder (ADHD) [231, 232], autism spectrum disorder (ASD) 
[233–236], and schizophrenia [237]. Results from a prospective pregnancy cohort 
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conducted in 487 mother-child pairs revealed that children born to mothers in the 
high 25(OH)D tertile (>50.7 nmol/l) had decreased risk of developing ADHD-like 
symptoms at 4 years of age, compared to children of women in the low 25(OH) D 
tertile (<38.4 nmol/l) [231]. In another prospective study conducted in 1650 
mother-child pairs, Morales et al. found an inverse association between maternal 
circulating levels of 25(OH)D in pregnancy and risk of developing ADHD-like 
at ages 4–5 years [232]. Using a case-control design study, Chen and colleagues 
reported that low maternal first-trimester serum levels of 25(OH)D was associ-
ated with increased odds of ASD diagnosis at age 3–7 years in the offspring [233]. 
Another study also found an increased risk of ASD in children who were born to 
mothers with vitamin D deficiency at mid-gestation [234]. In a large population-
based cohort of mothers and their children, gestational vitamin D deficiency was 
associated with a continuous measure of autism-related traits at 6 years [235]. 
Magnusson et al. also observed a relationship between maternal vitamin D defi-
ciency and risk of ASD with, but not without, intellectual disability [236]. Further, 
it has been demonstrated that low maternal vitamin D levels are associated with 
increased risk of schizophrenia within the subgroup of black but not white individ-
uals [237]. Although more robust studies needed, these results highlight the impor-
tance of maternal vitamin D status in offspring brain development and function.
7.  The association of maternal vitamin D status and child vitamin D 
status
Several lines of evidence suggest that there is a strong association between 
maternal 25(OH)D levels during pregnancy and newborn 25(OH)D concentrations 
at birth or in the early neonatal period [238–242]. Novakovic et al. reported that 
maternal circulating 25(OH)D levels were the most significant regulator of neonatal 
circulating vitamin D concentrations, even over the impact of genetic factors [243]. 
In another study, maternal characteristics explained 12.2%, and maternal 25(OH)D 
concentrations explained 32.1% of the neonatal vitamin D variance [13]. These results 
were confirmed in a systematic review reporting the range of correlation coefficients 
between maternal and newborn 25(OH)D concentrations, by region: European 
0.42–0.95, America 0.68–0.97, Western Pacific 0.19–0.85, South-East Asian 0.78–0.81, 
and Mediterranean 0.03–0.88 [106]. Therefore, since maternal vitamin D status in 
pregnancy is an important determinant of neonatal 25(OH)D concentrations, atten-
tion should be given not only to vitamin D-deficient pregnant women, but also to 
their newborns, especially if they are exclusively breast-fed [244].
8. Policy and best practices (supplementation/education)
Vitamin D deficiency is very prevalent across the globe among pregnant women 
[245]. The range of recommended vitamin D from during pregnancy varies from 
200 to 4000 IU/d worldwide. The American Pregnancy Association stated that 
pregnant women are recommended to have (100 μg/d) of vitamin D intake to 
reduce the risk of premature birth and infections which is a considerably higher 
amount of vitamin D compared to the recommended intake of 10 μg/d for women 
[246]. A daily intake of 600 IU is suggested during pregnancy in China to have 
healthy and balanced fetal growth [247]. In the United Kingdom, it is advised to 
have a maternal vitamin D intake of 400 IU/d. Switzerland follows the IOM dietary 
recommended nutrient intake. For pregnant/lactating women who are at risk of 
vitamin D deficiency, the advised vitamin D is 1500–2000 IU/d, and for women, 
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without deficiency, the recommended intake is 600 IU [248]. The ministry of 
health of New Zealand recommended 200 IU/d dietary intake of vitamin D [249]. 
Vitamin D requirements are higher among pregnant women (average 400 IU/d), 
and it is very important to maintain optimum serum level of vitamin D during 
maternity and for the fetus growth.
WHO encourages receiving vitamin D from a healthy and balanced diet [250]. 
Some recent studies suggest vitamin D food fortification can work as a means to 
improve vitamin D status among the overall population, which can benefit preg-
nant women as well [251]. Currently, Canada, United States, India, and Finland 
had a vitamin D food fortification policy. In North America, the foods that are 
naturally enriched by vitamin D, such as fatty fish, are quite expensive and are 
not readily available to the general population. A majority of vitamin D intake 
comes from fortified food in North America. The United States has a voluntary 
fortification policy, and Canada has both voluntary and mandatory fortification 
policies for specific foods. In the United States, milk including fluid, acidified, 
cultured, skimmed powder, evaporated milk (1.05 μg/100 g), soy-based beverages 
(1.25 μg/100 g), soy products (2.23 μg/100 g), margarine (8.3 μg/100 g), butter 
alternatives spread (8.25 μg/100 g), cheese alternatives spread (6.25 μg/100 g), 
yogurt (2.22 μg/100 g), fortified fruit juice (2.5 μg/240 mL), meal replacement 
products (2.5 μg/40 g), cheese products (2.02 μg/30 g), and enriched ready to eat 
cereal (8.75 μg/100 g), rice, cornmeal, noodle, macaroni (2.25 μg/100 g), farina 
(8.75 μg/100 g), and instant formula (1–25 μg/100 kcal) are vitamin D forti-
fied [252]. Mandatory fortified products in Canada are margarine (1.5 μg/10 g), 
infant formulas (10 μg /L), milk (powder, sterilized, flavored, skim, evaporated) 
(2.5 μg/250 mL), meal replacements (5% of DV/55 g), soy beverages, and soy 
beverage products (1.5–3 μg/250 mL) [253]. Some recent studies have shown a 
high prevalence of vitamin D inadequacies despite the mandatory fortification. 
The Department of Health, the Government of Canada, recently announced that 
vitamin D fortification levels need to be increased to alleviate the risk of rickets in 
children and osteomalacia in adults. It proposed that by the end of December 2022, 
vitamin D level in cow’s milk, and goat’s milk will be increased to 2 μg/100 ml (cur-
rent range 0.9–1.2 μg/100 ml) and in margarine, it will be increased 26 μg/100 g 
(current range 13.3–17.5 μg/100 g) [254]. Fluid milk (2.5 μg/250 mL) and mar-
garine (2 μg/10 g) are also fortified in Finland that had helped the general Finish 
population to improve vitamin D status. Similar to the United States, Canada forti-
fication policy, edible oil, margarine (0.55 μg/10 g), cow’s milk (1.25 μg/250 mL), 
and ready to eat cereals (5 μg/1/2-¾ cups) are fortified in Australia [255]. Similar 
approaches can be adopted by other countries to improve vitamin D inadequacy 
among pregnant women as well as the general population.
Supplement intake can also play an important role in improving vitamin D status 
among pregnant and lactating women. A recent study assessing maternal vitamin 
D inadequacies showed that vitamin D supplementation of ≤2000 IU/d minimizes 
the chance of neonatal mortality [256]. Taking a vitamin D supplement may also 
reduce the risk of PET, GDM, and low birth weight during pregnancy [257]. The 
current WHO guideline recommends 200 IU/d of vitamin D supplement intake 
among pregnant women with vitamin D deficiency to reduce the risk of PET, low 
birth weight, and preterm birth [258]. In Turkey, free supplementation of vitamin 
D (1200 IU/d) is provided to all women from early pregnancy to 6 months after 
delivery [259]. In Canada, pregnant women are suggested to take a vitamin D 
supplement of 400–600 IU/d [260]. A similar vitamin D supplementation intake 
approach (400 IU/d) is followed in New Zealand as well during pregnancy The 
United Kingdom Health Department provides free vitamin D supplementation to 
pregnant women and newborn children and recommends taking 10 μg (400 IU) of 
Vitamin D Deficiency
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vitamin D supplements during pregnancy and lactation [261]. Taking vitamin D 
enriched food and supplement can be advised to maintain optimum serum levels 
during pregnancy.
9. Conclusion
The existing evidence reveals the importance of adequate vitamin D status dur-
ing pregnancy for the mother, fetus, and child, although more studies are needed to 
clarify the exact mechanisms. In a situation where optimal vitamin D status cannot 
be achieved through diet and sun exposure, food fortification and supplementation 
seem to be proper approaches. Policies for vitamin D fortification vary across the 
globe, while more countries are recognizing the importance of vitamin D. The cur-
rent evidence indicates the need for vitamin D supplementation in pregnant women 
in a situation that fortification alone cannot address the needs [262]. To our knowl-
edge, only a few countries have free supplementation policies during pregnancy and 
early life. Effective systematic approaches by relevant agencies and governments are 
required to synthesize evidence-based recommendations for vitamin D supplemen-
tation during pregnancy and customize interventions considering cultural factors 
to ensure the optimal vitamin D status for pregnant women and their newborns.
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